Options for Patients with Polycythemia VeraVideo Categories: Polycythemia Vera
Supported through funding from Incyte
In Pursuit of Targeted Therapies
As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.
Incorporating Value and Cost-Awareness in Drug Development
Dr. Jorge Cortes ponders the cost of treatment versus the improvement in the standard of care, asking if what we are gaining is really worth the rising cost.